Objective-To assess the use of transcatheter occlusion of a persistent arterial duct in symptomatic children < 2 years of age.
the youngest infant weighing 2-9 kg. The diagnosis was established before operation in all patients by cross sectional echocardiography. Interventions-Transcatheter occlusion of a haemodynamically important persistent arterial duct was performed with the Rashkind ductal umbrella. In the past year the front loading technique has been used to place the 12 mm umbrella through a 6 F (French) sheath and the 17 mm device through a 8 F sheath so extending the indications for their use.
Results-Umbrelilas were successfully placed in 25 (86*2%) infants and there was symptomatic improvement in all. There were no deaths or severe complications. The four failures occurred early in the series. They were caused by kinking of the 11 F sheath in two cases and embolisation into the left pulmonary artery in one case. The (12 mm umbrella through a 6 F sheath in one, 17 mm umbrella through a 8 F sheath in two). The four failures were encountered early in the series. Kinking of the long 11 F sheath with a 17 mm device was the reason for failure in two cases. In one case a 12 mm umbrella embolised to the left pulmonary artery and was successfully snared and retrieved transvenously but further attempts were abandoned because of prolonged procedure time. Finally, a large duct measuring > 9 mm in one infant was impossible to occlude satisfactorily with a 17 mm umbrella and the procedure was again abandoned before release of the device. After discussion with the parents three of the patients were referred for surgery, the patient in whom the device embolised underwent a successful implantation two months later. We have previously reported one case in this series who developed severe haemolytic anaemia after placement of a 17 mm umbrella.6 A second 17 mm device was implanted four weeks later to completely stop the shunt and resolve the haemolysis.
Follow up ranged from three to 29 months with a mean of 13 months. There was resolution of symptoms in all patients. Only two infants had clinically evident residual shunts at last follow up (both had a 17 mm umbrella), the rest were detected only on echocardiography. Colour flow Doppler showed ductal shunts in 13 children (55 4%) on the first day and seven (26 3%) after six months. At most recent follow up, only three patients had residual shunts, all had been followed up for > 1 year. Residual shunts on colour flow mapping were found at six months after implantation in all seven infants who had the 17 mm umbrella and these persisted in three at one year. Conversely all 18 children who had the 12 mm umbrella had no clinical or colour Doppler evidence of residual shunting at six months. There were two cases with turbulent colour flow in the left pulmonary artery (one with a 17 mm, one with a 12 mm device) without obvious pressure gradient at the time of the study. This has resolved by one year in both. In the smallest child there was turbulence in the descending aorta due to protrusion of the distal arms. There was no pressure gradient but turbulence has persisted at the most recent follow up six months after the procedure.
Discussion
Previous studies have confirmed the safety and effectiveness of transcatheter umbrella occlusion of the persistent arterial duct.78 Indeed, it is now the treatment of first choice in many centres. The average age of children in these earlier reports was well into school age and relatively few children < 2 years have been reported. Our study shows that similar results can be achieved in this younger age group. Successful placement was achieved in 26 of 29 children in whom it was attempted (89 6%), complete closure was shown by colour flow mapping in 23 of them (88 4%). There was only one patient with an important complication, that of severe haemolysis, which resolved with placement of a second device.6 A previous study by Musewe and coworkers has highlighted the potential problem of left pulmonary arterial stenosis. 7 We were particularly concerned that this might be a problem in our younger and smaller children, but detailed cross sectional echocardiography and colour flow mapping showed left pulmonary artery turbulence in only two patients immediately after the procedure and showed all patients to be normal six months after implantation. Ottenkamp et al found an incidence of left pulmonary arterial turbulence of 5 5%, seen only with the 17 mm device.8 A 17 mm device was used in only seven of our patients and the low incidence of left pulmonary artery problems in our series might suggest that the problem is related to the design of the larger device rather than the relative size of umbrella and artery. If this is the case, then earlier closure in smaller children with more frequent use of the 12 mm device may ultimately prove to be less complicated. We did not see any tricuspid valve damage or regurgitation on echocardiographic screening at the end of the procedure or during follow up. Although one paper reports transoesophageal echocardiographic monitoring of interventional cardiac catherisation,9 and a more recent paper has reported damage to the tricuspid valve during balloon dilatation of the pulmonary valve in children > 6 months of age,10 this does not seem to be a problem even with the use of relatively large delivery catheters. Therefore monitoring by means of transesophageal echocardiography during umbrella occlusion of a persistent arterial duct in children < 2 years, although advocated by some, is not essential.
The front loading technique, described by Perry and Lock enables the umbrella to be delivered through a smaller trans-septal sheath and therefore to smaller infants. 4 They positioned the 12 mm umbrella through a 7 F and the 17 mm through a 9 F sheath. We have gone down still further in size, positioning the 12 mm umbrella through a 6 F and the 17 mm through a 8 F sheath. This extends the indications of the device and overcomes the problem of kinking of larger long sheaths in small children, which led to failure in two of the patients in the early part of the series.
Our incidence of residual shunts is no different to other reports in older children." 12 Our 100% closure rate with the 12 mm device is particularly encouraging. Only three patients had persisting shunts at one year after the procedure, all of whom had a 17 mm device implanted. Our current policy in older children is to implant a second umbrella if there is a significant residual shunt two years after the first procedure, and so it is possible that a second device will be required in these patients.
In summary, we have shown that transcatheter occlusion of the persistent arterial duct is effective and safe in small children.
Front loading the device into a smaller sheath extends the age and size limits of the proce-dure and does not seem to increase the risk of complications. As a consequence, catheter closure has become the treatment of choice for the persistent arterial duct even in small infants in our hospital.
